Stocklytics Platform
Asset logo for symbol GBIO
Generation Bio Co
GBIO40
$2.18arrow_drop_down6.03%-$0.14
Penny Stock
Asset logo for symbol GBIO
GBIO40

$2.18

arrow_drop_down6.03%

Performance History

Chart placeholder
Key Stats
Open$2.32
Prev. Close$2.32
EPS-2.39
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$156.84M
PE Ratio-
LOWHIGH
Day Range2.16
2.32
52 Week Range0.86
4.92
Ratios
EPS-2.39

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Generation Bio Co (GBIO)

Generation Bio Co (GBIO) is a leading biotechnology company focused on developing innovative genetic medicines to treat a range of rare and prevalent genetic diseases. The company is pioneering a novel non-viral gene therapy platform called closed-ended DNA (ceDNA) technology, which has the potential to address limitations of current gene therapy approaches.
The stock price history of Generation Bio Co (GBIO) reflects the growing interest and confidence in the company's potential. Since its initial public offering in 2020, the stock has experienced steady growth, driven by positive news and advancements in its genetic medicine development programs.
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Cameron Geoffrey McDonough M.D.
Headquarters
Cambridge
Employees
150
Exchange
NASDAQ
add Generation Bio Co to watchlist

Keep an eye on Generation Bio Co

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Generation Bio Co's (GBIO) price per share?

The current price per share for Generation Bio Co (GBIO) is $2.18. The stock has seen a price change of -$0.14 recently, indicating a -6.03% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Generation Bio Co (GBIO)?

For Generation Bio Co (GBIO), the 52-week high is $4.92, which is 125.92% from the current price. The 52-week low is $0.86, the current price is 153.49% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Generation Bio Co (GBIO) a growth stock?

Generation Bio Co (GBIO) has shown an average price growth of 0.41% over the past three years. It has received a score of 7 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Generation Bio Co as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Generation Bio Co (GBIO) stock price performance year to date (YTD)?

As of the latest data, Generation Bio Co (GBIO) has a year-to-date price change of 17.2%. Over the past month, the stock has experienced a price change of -11.02%. Over the last three months, the change has been -34.34%. Over the past six months, the figure is -21.3%.
help

Is Generation Bio Co (GBIO) a profitable company?

Generation Bio Co (GBIO) has a net income of -$126.61M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 10.86% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -530.73% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $5.9M, although specific revenue growth data is currently not available. The gross profit is $641K. Operating income is noted at -$138.56M. Furthermore, the EBITDA is -$106.7M.
help

What is the market capitalization of Generation Bio Co (GBIO)?

Generation Bio Co (GBIO) has a market capitalization of $156.84M. The average daily trading volume is 120.2K, indicating the stock's liquidity and investor engagement.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media